Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? Yes
Write-up: Pericardial effusion; Myocarditis; Dyspnoea; Thorax pain; Tachycardia; Cervical pain; Headache; patient died; This is a spontaneous report from a non-contactable pharmacist downloaded from the regulatory authority. Regulatory authority number DE-PEI-202100029368. A 35-year-old female patient received bnt162b2 (COMIRNATY, lot number: unknown), via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunisation. The patient''s medical history and concomitant medications were not reported. The patient experienced pericardial effusion, myocarditis, dyspnoea, thorax pain, tachycardia, cervical pain, and headache; all on an unspecified date. The events pericardial effusion, myocarditis, dyspnoea was reported as life-threatening. The patient died on 30Jan2021. Autopsy was not performed. The patient had not recovered from the event pericardial effusion, myocarditis, dyspnoea, thorax pain, tachycardia, cervical pain, and headache. No follow-up attempts possible, batch/lot number cannot be obtained. No further information expected.; Reported Cause(s) of Death: patient died
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166